A biopsy system

NeoNavia is an innovative biopsy system in late-stage development. The system is built on a patented micro-pulse technology based on research at the Karolinska Institutet in Sweden. NeoNavia is designed to offer accurate lesion targeting and high tissue yield for correct diagnosis and individualized treatment. A commercial launch is expected in 2020.

NeoNavia is intended to be used under ultrasound guidance and consists of:

1. A Base Unit
2. A Handheld driver
3. Three types of biopsy needles

Each needle type is driven by the micro-pulses enabling high precision and control when inserting and positioning the biopsy needle in a suspicious lesion.

The base unit generates pressurized air needed for the micro-pulses as well as generates negative pressure for the vacuum suction function.

The handheld driver is the user interface with activation buttons for all functions.

The three needle types contain micro-pulse versions of a core needle (CNB), a vacuum assisted biopsy needle (VAB) and an innovative open tip micro-pulse needle of same size as core needles.

Read more on the three types of needles